These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1801354)

  • 21. [Combined immunoprophylaxis induces changes in anti-hepatitis B surface protein titer in infants born to mothers with positivity for hepatitis B surface antigen].
    Wang J; Feng YL; Liu MH; Bai Y; Feng DH; Yuan NX; Du DQ; Feng WH; Liu HL; Yang Y; Liu JF; He YL; Song HX; Liu Y; Zhao YR; Chen TY
    Zhonghua Gan Zang Bing Za Zhi; 2013 Aug; 21(8):580-3. PubMed ID: 24119736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune response after vaccination with recombinant hepatitis surface antigen in maintenance hemodialysis patients and healthy controls.
    Allegra V; Vasile A; Maschio M; Mengozzi G
    Nephron; 1992; 61(3):339-40. PubMed ID: 1386908
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vaccination of newborns of HBsAg-positive carrier mothers with a recombinant DNA hepatitis B vaccine.
    Cadranel S; Zeghlache S; Fernandez S; Safary A; André F
    Postgrad Med J; 1987; 63 Suppl 2(736):159-60. PubMed ID: 3317355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study.
    Bialek SR; Bower WA; Novak R; Helgenberger L; Auerbach SB; Williams IT; Bell BP
    Pediatr Infect Dis J; 2008 Oct; 27(10):881-5. PubMed ID: 18756185
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunogenicity of hepatitis B vaccine in preterm and full term infants vaccinated within the first week of life.
    Freitas da Motta MS; Mussi-Pinhata MM; Jorge SM; Tachibana Yoshida CF; Sandoval de Souza CB
    Vaccine; 2002 Feb; 20(11-12):1557-62. PubMed ID: 11858862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Study on the immuno-effects and influencing factors of Chinese hamster ovary (CHO) cell hepatitis B vaccine among adults, under different dosages].
    Zhang W; Lin CY; Han LL; Li LQ; Gao P; Lin H; Gong XH; Huang F; Tang YQ; Ma JX; Zhang HY; Wang C; Yang P; Li H; Sun MP; He X; Pang XH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Jul; 31(7):767-70. PubMed ID: 21162840
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recombinant hepatitis B vaccine (Engerix-B): a review of its immunogenicity and protective efficacy against hepatitis B.
    Keating GM; Noble S
    Drugs; 2003; 63(10):1021-51. PubMed ID: 12699402
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis B vaccination of newborn infants: clinical study of new vaccine formulation and dose regimen.
    Lee KS; Lee H; Moon SJ; Choi KJ; Kim KH; Kim CW; Chung WS; Choi TY
    Hepatology; 1987; 7(5):941-5. PubMed ID: 2958400
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The long-term efficacy of Chinese hamster ovary cell derived hepatitis B vaccine after being used for 14-16 years in Chinese rural communities.
    Wang F; Ma J; Hao Z; Zhang Z; Zhang X; Gao Z; Bi S; Shen L; Qiu F; Zhao Y
    Vaccine; 2015 Jan; 33(2):294-7. PubMed ID: 25454089
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Evaluation of the efficacy of a recombinant hepatitis B vaccine].
    Polywka S; Gatermann S; von Wulffen H; Laufs R
    Immun Infekt; 1988 Oct; 16(5):175-8. PubMed ID: 3209233
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Anti-HBs persistence after revaccination with three doses of hepatitis B vaccines among non-responsive adults: 24-month of follow-up].
    Zhang L; Lyu J; Yan B; Liu J; Feng Y; Chen S; Zhou L; Liang X; Cui F; Wang F; Xu A
    Zhonghua Yu Fang Yi Xue Za Zhi; 2015 Sep; 49(9):782-7. PubMed ID: 26733135
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Integration of hepatitis B vaccination into rural African primary health care programmes.
    Schoub BD; Johnson S; McAnerney JM; Blackburn N; Kew MC; McCutcheon JP; Carlier ND
    BMJ; 1991 Feb; 302(6772):313-6. PubMed ID: 1825799
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Results of vaccinated infants born to HBsAg-positive mothers with different hepatitis B vaccines and doses.
    Kuru U; Turan O; Kuru N; Sağlam Z; Alver A
    Turk J Pediatr; 1995; 37(2):93-102. PubMed ID: 7597774
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Post-vaccination serologic testing of infants born to hepatitis B surface antigen positive mothers in 4 provinces of China.
    Wang F; Zhang G; Zheng H; Miao N; Shen L; Wang F; Dong P; Du F; Chen C; Zhang X; Cui F
    Vaccine; 2017 Jul; 35(33):4229-4235. PubMed ID: 28651839
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Anti-HBs persistence after revaccination with three doses of hepatitis B vaccine among non-responsive adults: a 4-year of follow-up study].
    Zhang L; Yan BY; Lyu JJ; Liu JY; Feng Y; Wu WL; Cao CZ; Chen SY; Zhou LB; Liang XF; Cui FQ; Wang FZ; Zhang GM; Xu AQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Jun; 50(6):497-502. PubMed ID: 27256728
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surface antibody and cytokine response to recombinant Chinese hamster ovary cell (CHO) hepatitis B vaccine.
    Zhang W; Han L; Lin C; Wang H; Pang X; Li L; Gao P; Lin H; Gong X; Tang Y; Ma J; Zhang H; Wang C; Yang P; Li H; Sun M; He X
    Vaccine; 2011 Aug; 29(37):6276-82. PubMed ID: 21722684
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of hepatitis B in children in a high risk New Zealand community, and control using recombinant DNA vaccine.
    Milne A; Heydon JL; Hindle RC; Pearce NE
    N Z Med J; 1989 Apr; 102(866):182-4. PubMed ID: 2523525
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined passive and active immunization for interruption of perinatal transmission of hepatitis B virus in Taiwan.
    Lo KJ; Tsai YT; Lee SD; Yeh CL; Wang JY; Chiang BN; Wu TC; Yeh PS; Goudeau A; Coursaget P
    Hepatogastroenterology; 1985 Apr; 32(2):65-8. PubMed ID: 3159639
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis B immunisation with a reduced number of doses in newborn babies and children.
    Piazza M; Picciotto L; Villari R; Guadagnino V; Orlando R; Isabella L; Macchia V; Memoli AM; Vegnente A; Borrelli AM
    Lancet; 1985 Apr; 1(8435):949-51. PubMed ID: 2859412
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of antigen dosage on the hepatitis B vaccine response in infants born to hepatitis B-uninfected and hepatitis B-infected mothers.
    Kang G; Ma F; Chen H; Yang Y; Guo S; Wang Z; Liang X; Li L; Cui F; Zhang L
    Vaccine; 2015 Aug; 33(33):4093-9. PubMed ID: 26144895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.